Literature DB >> 16840600

An analysis of the effectiveness of heat-killed lactic acid bacteria in alleviating allergic diseases.

T Sashihara1, N Sueki, S Ikegami.   

Abstract

Allergic diseases are reported to be caused by a skew in the balance between T helper type 1 and 2 cells. Because some lactic acid bacteria have been shown to stimulate IL-12 (p70) production, which in turn shifts the balance between the T helper type 1 and 2 cell response from the latter to the former, they have the potential to either prevent or ameliorate disease conditions or both. They have therefore been extensively studied in the recent past for their probiotic activities. Nevertheless, much less information is available concerning the microbial factors that determine the strain-dependent ability to affect the production of cytokines. The objectives of our study were first to select potentially probiotic lactobacilli that strongly stimulate cytokine production in vitro, and then to determine whether the selected Lactobacillus strains could suppress antigen-specific IgE production in vivo by using allergic model animals. Finally, our investigation was extended to analyze which bacterial components were responsible for the observed biological activity. Twenty strains of heat-killed lactobacilli isolated from humans were screened for their stimulatory activity for the production of IL-12 (p70) by murine splenocytes in vitro. The results showed that some strains of Lactobacillus plantarum and Lactobacillus gasseri had a higher stimulatory activity for IL-12 (p70) production than the other lactobacilli tested; however, this effect was strain dependent rather than species dependent. Oral administration of the heat-killed strains that showed higher stimulatory activity for IL-12 (p70) production tended to reduce the serum antigen-specific IgE levels in ovalbumin-sensitized BALB/c mice compared with the controls. Among the lactobacilli tested, L. gasseri OLL2809 showed the highest activity in reducing the level of antigen-specific IgE. Furthermore, the stimulatory activity for IL-12 (p70) production was found to be reduced after treating the lactobacilli with N-acetyl-muramidase and to be positively correlated with the amount of peptidoglycan in the cells. The present data suggest that L. gasseri OLL2809 is a good candidate for potential probiotics in terms of either the prevention or amelioration of allergic diseases or both. In addition, the strain-dependent stimulatory activity for IL-12 (p70) production was found to be due, at least in part, to the amount of peptidoglycan present in the cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840600     DOI: 10.3168/jds.S0022-0302(06)72557-7

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  29 in total

1.  Effects of Lactobacillus plantarum Strain OLL2712 Culture Conditions on the Anti-inflammatory Activities for Murine Immune Cells and Obese and Type 2 Diabetic Mice.

Authors:  T Toshimitsu; S Ozaki; J Mochizuki; K Furuichi; Y Asami
Journal:  Appl Environ Microbiol       Date:  2017-03-17       Impact factor: 4.792

2.  Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model.

Authors:  Lorenzo Drago; Lucia Nicola; Enrico Iemoli; Giuseppe Banfi; Elena De Vecchi
Journal:  BMC Res Notes       Date:  2010-02-25

3.  Probiotics: Potent Immunomodulatory Tool Against Allergy.

Authors:  Umesh Kr Shandilya; Sagar Jadhav; Vandana Panwar; V K Kansal
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

4.  Lactobacillus gasseri OLL2809 and its RNA suppress proliferation of CD4(+) T cells through a MyD88-dependent signalling pathway.

Authors:  Ayako Yoshida; Kiyoshi Yamada; Yasumasa Yamazaki; Toshihiro Sashihara; Shuuji Ikegami; Makoto Shimizu; Mamoru Totsuka
Journal:  Immunology       Date:  2011-06-01       Impact factor: 7.397

5.  Lactobacillus gasseri OLL2809 is effective especially on the menstrual pain and dysmenorrhea in endometriosis patients: randomized, double-blind, placebo-controlled study.

Authors:  Hiroyuki Itoh; Masayuki Uchida; Toshihiro Sashihara; Zai-Si Ji; Ji Li; Qianjue Tang; Shuang Ni; Linyi Song; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2010-12-10       Impact factor: 2.058

6.  Lactobacillus gasseri OLL2809 inhibits development of ectopic endometrial cell in peritoneal cavity via activation of NK cells in a murine endometriosis model.

Authors:  Hiroyuki Itoh; Toshihiro Sashihara; Akira Hosono; Shuichi Kaminogawa; Masayuki Uchida
Journal:  Cytotechnology       Date:  2011-03-16       Impact factor: 2.058

Review 7.  Microbiome/microbiota and allergies.

Authors:  Yuzaburo Inoue; Naoki Shimojo
Journal:  Semin Immunopathol       Date:  2014-10-18       Impact factor: 9.623

8.  Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents.

Authors:  J Ezendam; A de Klerk; E R Gremmer; H van Loveren
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

Review 9.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

10.  Effect of heat-killed Escherichia coli, lipopolysaccharide, and muramyl dipeptide treatments on the immune response phenotype and allergy in neonatal pigs sensitized to the egg white protein ovomucoid.

Authors:  Julie Schmied; Prithy Rupa; Sarah Garvie; Bruce Wilkie
Journal:  Clin Vaccine Immunol       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.